Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients
在以中年多发性骨髓瘤患者为主的、符合移植条件的患者队列中,接受硼替佐米、环磷酰胺和地塞米松诱导治疗的患者长期生存率得到改善。
期刊:
影响因子:
doi:10.5144/0256-4947.2024.93
Abdrabou, Ahmed Kotb; Al Sharif, Fahad; El Fakih, Riad; Zahrani, Hazaa Al; Al Yamany, Ruah; Saleh, Mostafa; Alhayli, Saud; Al Somali, Zakia; Alotaibi, Ahmad; AlShaibani, AlFadel; Deeba, Farah; Asif, Maryam; Ahmed, Syed Ahmed Osman Ali; Al Fraih, Feras; Shaheen, Marwan; Alahmari, Ali; Rasheed, Walid; Chaudhri, Naeem Arshad; Al Mohareb, Fahad; Aljurf, Mahmoud; Hanbali, Amr